Pregnenolone 100 60 Tablet

Pregnenolone 100 Mg 60 Tabs Time-release pregnenolone (plant source) for superior utilization. In the body, pregnenolone is metabolized from cholesterol by the cytochrome P450 enzyme. It serves as a parent hormone for all adrenal cortical steroids, including progesterone, testosterone, dehydroepiandrosterone, dihydrotestosterone, aldosterone, cortisol and estradiol. Pregnenolone levels decrease with age, during periods of fatigue, or in conditions of inadequate cholesterol production.* Suggested Use: As a dietary supplement, 1 tablet daily, or as directed by a healthcare practitioner. Serving Size 1 tablet Servings per container 60 Amount per serving: Pregnenolone 100 mg Other ingredients: Dicalcium phosphate, stearic acid, magnesium stearate, cellulose, silicon dioxide. This nutrient is of the highest quality and purity obtainable, free of all common allergens (antigens), and does not contain preservatives, diluents, or artificial additives. Variations in product color may occur. Keep in a cool, dry place, tightly capped. WARNING: NOT FOR USE BY INDIVIDUALS UNDER THE AGE OF 18 YEARS. DO NOT USE IF PREGNANT OR NURSING. Consult a physician or licensed qualified health care professional before using this product if you have, or have a family history of, prostate cancer, prostate enlargement, heart disease, low good cholesterol (HDL), or if you are using any other dietary supplement, prescription drug, or over-the-counter drug. Do not exceed recommended serving. Exceeding recommended serving may cause serious adverse health effects. Possible side effects include acne, hair loss, hair growth on the face (in women), aggressiveness, irritability, and increased levels of estrogen. Discontinue use and call a physician or licensed qualified health care professional immediately if you experience






An extra degree of precision will be added to radiation treatments for prostate cancer at Washington University School of Medicine in St. Louis following the installation of two new technologies in the Department of Radiation Oncology.
“Patients’ choices in terms of what therapy to have for prostate cancer really are based on their individual situation and their acceptance of certain risks or benefits from that treatment.” Drs. Tewari (leader in prostate cancer research and surgery) and Schlegel (Department Chairman) of Cornell Urology discuss “treatment choices” in the context of patient profile and the acceptance of certain risks. They emphasize the importance of having all the right knowledge and being an informed prostate cancer patient when facing prostate cancer treatment decisions. Prostate cancer requires you to get through all the physician bias and make informed decisions in partnership with your prostate cancer doctor.